ADVANCED LUNG NON-SMALL CELL CARCINOMA
Clinical trials for ADVANCED LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo vaccine and pill takes aim at hard-to-treat lung cancer
Disease control Not yet recruitingThis study tests whether adding a cancer vaccine (CIMAVAX-EGF) to standard targeted pills (sotorasib or adagrasib) can better control advanced lung cancer with a KRAS G12C mutation. About 29 adults with stage III or IV non-small cell lung cancer will receive the vaccine plus one …
Matched conditions: ADVANCED LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New drug duo aims to reboot immune system against tough lung cancers
Disease control Not yet recruitingThis study is testing whether a new drug, SX-682, combined with an existing immunotherapy drug (atezolizumab), can help control advanced non-small cell lung cancer that has worsened after standard chemotherapy and immunotherapy. It aims to see if this combination can help the pat…
Matched conditions: ADVANCED LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 23, 2026 12:43 UTC